covid news, page-140

2021 AWARDS (Judges: David Langsam, Tim Boreham)
Chair of the Year
This award is for those admirals of the fleet who give strategic directions to the captains of
their ships. If the objective is unclear, the mission will fail.
The Chair of the Year was easy. Imugene, Arovella (Suda), Chimeric and now
Radiopharm - Paul Hopper is the chair about town.
We do have to address his critics. Paul finds interesting technologies at universities and
institutes and wraps a company around them, which he then sells to an ASX-listed
company or undertakes an initial public offer. Some people don’t like Mr Hopper retaining
control of the company and he often has shares written into the prospectus. Earlier this
year, both Paul and Imugene CEO Leslie Chong exercised options around 4.5 cents into
shares worth about 45 cents.
Our main problem with this practice is that we didn’t think of it first and Paul hasn’t asked
us to join any of his early-stage deals. It’s all above board, transparent and legal, even if
it’s not usual. But we like unusual. It’s called innovation.
2021’s Chair of the Year goes to Paul Hopper.